EXCHANGE AND SETTLEMENT AGREEMENTExchange and Settlement Agreement • October 5th, 2020 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Patent Network Law Group (the “Vendor”) enters into this Agreement (this “Agreement”) with RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company”) on September 30, 2020, whereby Vendor will exchange and settle certain accounts payable owed to the Vendor by the Company for shares of Series H 2% Voting, Non-Participating, Convertible Preferred Stock, par value $0.001 (the “Preferred Stock”), of the Company (the “Exchange and Settlement”).
